middle.news
Bio-Gene Raises A$3.21m to Advance Flavocide Approval and Qcide Production
9:59am on Tuesday 26th of May, 2026 AEST
•
Agriculture
Read Story
Bio-Gene Raises A$3.21m to Advance Flavocide Approval and Qcide Production
9:59am on Tuesday 26th of May, 2026 AEST
Key Points
A$2.71m placement plus A$0.5m underwritten SPP
Funds to complete Flavocide regulatory studies for Australian approval
Increased Qcide production to meet partner demand
Options attached to raise subject to shareholder approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bio-Gene Technology (ASX:BGT)
OPEN ARTICLE